Pediatric Diseases

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis who are anti-acetylcholine receptor or anti-muscle-specific kinase antibody positive, according to the manufacturer.

Only 49.1% of available pediatric rheumatology fellowship slots were filled for 2025 on this year’s Match Day, representing a sharper drop-off for the specialty after years of trickling declines.

Meta Pharmaceuticals has received FDA rare pediatric disease designation for its investigational new drug META-001-PH, according to a press release.

The FDA has authorized the first chimeric antigen receptor T-cell clinical trial for children with systemic lupus erythematosus.

Arcutis Biotherapeutics has submitted a supplemental new drug application to the FDA for roflumilast cream 0.15% for mild to moderate atopic dermatitis treatment in adults and children aged 6 years and older, according to a press release.

WAILEA, Hawaii — A recent increase in invasive group A streptococcal infections in pediatric patients should be monitored and patients treated appropriately, according to a presentation at the Maui Derm meeting.

Researchers identified functionally relevant risk factors for pediatric primary focal segmental glomerulosclerosis in African American children, according to data published in the American Journal of Kidney Diseases.

Published results showed a more robust pediatric trauma system may have a significant association with improved pediatric mortality after traumatic injury.

Dermavant Sciences announced positive results from its maximal usage study of Vtama cream in the treatment of atopic dermatitis for children aged as young as 2 years, according to a company press release.

Since 2000, the Acute Disease Quality Initiative has met to discuss kidney disease in adults, but in 2021, Rajit K. Basu, MD, coordinated the first meeting to focus solely on pediatric AKI critical care in nephrology.